{
    "2019-11-07": [
        [
            {
                "time": "2023-10-15",
                "original_text": "David Carlson Trims Charles Schwab, Exits Verizon",
                "features": {
                    "keywords": [
                        "Carlson",
                        "Trims",
                        "Schwab",
                        "Exits",
                        "Verizon"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "telecommunications"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Aerie (AERI) Q3 Loss Wider, Sales Beat, Guidance Slashed",
                "features": {
                    "keywords": [
                        "Aerie",
                        "Q3",
                        "Loss",
                        "Wider",
                        "Sales",
                        "Beat",
                        "Guidance",
                        "Slashed"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "[video]Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Long-Term",
                        "Outlook",
                        "Murky",
                        "UBS",
                        "Lowering",
                        "Price",
                        "Target"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}